Myomo Announces First Adolescent Patients to be Fitted with MyoPro
November 14 2018 - 08:05AM
Business Wire
Robotic lightweight wearable device empowers
young adults with arm paralysis to live independently, while also
reducing healthcare costs
Myomo, Inc., a wearable medical robotics company, has achieved
recent momentum fitting and delivering MyoPro to adolescent users.
Approved to assist young adults suffering from any disease or
injury leaving them with a paralyzed or weakened arm, MyoPro is
restoring motion and functionality to adolescents with conditions
such as cerebral palsy, brachial plexus injury, and more. MyoPro is
now being tested on Acute Flaccid Myelitis ("AFM") patients with
promising results.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20181114005049/en/
The first adolescent user to be fitted, Zeke Dees, has regained
his independence after almost a decade of only having use of one
arm and credits his MyoPro device for transforming his life. When
he was 8 years old, he suffered a life-altering ATV accident. At
the hospital, doctors discovered that he suffered a brain injury, a
spinal cord injury, and a brachial plexus injury. Zeke received
surgery and significant, comprehensive therapy and made a
remarkable recovery, except for the brachial plexus injury (BPI) to
his shoulder, leaving his arm completely paralyzed. Subsequently,
Zeke had to try to do everything again with one functional arm.
Use of the MyoPro robotic brace is continuing to expand and is
reaching youth through highly regarded rehabilitation centers
including Easterseals, Shriner’s Hospitals and esteemed children’s
hospitals in several cities including Cleveland, Boston, Dallas and
Cincinnati. MyoPro has more recently been fitted and delivered to
cerebral palsy patients at some of these facilities with promising
early results.
“The brachial plexus is the network of nerves that sends signals
from your spinal cord to your shoulder, arm, and hand. There
aren’t a lot of non-invasive, clinical interventions for BPI that
produce the same results as the MyoPro,” said Liz May, pediatric
occupational therapist at Shriners Hospital for Children in
Chicago. “With the help of the MyoPro, we are seeing patients
drastically improve their range of motion, spontaneous use, and
function of their involved upper extremity, despite paralysis. This
device has allowed my patients to find a new state of independence,
which has completely transformed their outlook on life.”
After his injury, Zeke tried to establish a new sense of
normalcy and considered the reality of spending the rest of his
life only having one functioning arm. Since being fitted for a
MyoPro, Zeke has completely changed his attitude and has been able
to resume activities his injury previously hindered him from doing
such as cutting his food, playing pool and helping with chores
around the house.
“My MyoPro device has changed my life dramatically. Not only has
it allowed me to gain my independence back, but it’s brought
strength back to my left arm,” said Zeke Dees, an adolescent Myomo
user. “I got my brace when I was 17 and I can’t imagine life
without it. It’s already helped me with the activities of daily
living that I couldn’t do before.”
Paul R. Gudonis, Chairman and CEO of Myomo, said, “Zeke is just
one of many success stories from Myomo patients who have
significantly regained the use of a once paralyzed limb. His
personal story is yet another example of Myomo’s commitment to
helping restore function in the arms and hands of individuals who
are suffering from the effects of a neuromuscular disease or
injury. We are looking forward to providing more adolescents a
chance to improve their quality of life, just like Zeke has.”
Through patented technology, the MyoPro orthosis can offer
individuals living with a paralyzed arm the opportunity to regain
function, increasing safety and quality of life in the home and
reducing healthcare costs associated with managing upper limb
paralysis.
For more information about MyoPro for adolescents, please
visit www.myomo.com/adolescents.
About Myomo
Myomo, Inc. is a wearable medical robotics company that offers
expanded mobility for those suffering from neurological disorders
and upper limb paralysis. Myomo develops and markets the MyoPro
product line. MyoPro is a powered upper limb orthosis designed to
support the arm and restore function to the weakened or paralyzed
arms of patients suffering from CVA stroke, brachial plexus injury,
traumatic brain or spinal cord injury, ALS or other neuromuscular
disease or injury. It is currently the only marketed device that,
sensing a patient’s own EMG signals through non-invasive sensors on
the arm, can restore an individual’s ability to perform activities
of daily living, including feeding themselves, carrying objects and
doing household tasks. Many are able to return to work, live
independently and reduce their cost of care. Myomo is headquartered
in Cambridge, Massachusetts, with sales and clinical professionals
across the U.S. For more information, please visit
www.myomo.com.
Forward Looking Statements
This press release contains forward-looking statements regarding
the Company's future business expectations, including adoption of
MyoPro by adolescent users, which are subject to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
These forward-looking statements are only predictions and may
differ materially from actual results due to a variety of factors.
Our actual results could differ materially from those anticipated
in these forward looking statements for many reasons, including,
without limitation, risks related to regulatory approval and market
acceptance of our products, and the other risk factors contained in
our filings made with the Securities and Exchange Commission. More
information about factors that potentially could affect Myomo's
business and financial results is included in Myomo's filings with
the Securities and Exchange Commission. The Company cautions
readers not to place undue reliance on any such forward-looking
statements, which speak only as of the date made. The Company
disclaims any obligation subsequently to revise any forward-looking
statements to reflect events or circumstances after the date of
such statements or to reflect the occurrence of anticipated or
unanticipated events.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20181114005049/en/
Investor Relations:PCG AdvisoryVivian Cervantes,
646-863-6274vivian@pcgadvisory.comorPublic Relations:Matter
CommunicationsMeredith Krim, 617-874-5203myomo@matternow.com
Myomo (AMEX:MYO)
Historical Stock Chart
From Feb 2024 to Mar 2024
Myomo (AMEX:MYO)
Historical Stock Chart
From Mar 2023 to Mar 2024